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ABSTRACT   22 
Background 23 
The blue wavelengths within the visible light spectrum are intrinisically antimicrobial, 24 
and can photodynamically inactivate the cells of a wide spectrum of bacteria (Gram-25 
positive and -negative) and fungi.  Furthermore, blue light is equally effective against 26 
both drug sensitive and resistant members of target species, and  (in contrast to UV 27 
radiation), is less detrimental to mammalian cells.  28 
Blue light is currently used for treating acnes vulgaris, and Helicobacter pylori infections; 29 
the utility for decontamination and treatment of wound infections is in its infancy. 30 
Furthermore, limited studies have been performed on bacterial biofilms; the key growth 31 
mode of bacteria involved in clinical infections.  32 
Here we report the findings of a multicentre in vitro study performed to assess the 33 
antimicrobial activity of 400 nm blue light against bacteria in both planktonic and biofilm 34 
growth modes.  35 
Methods 36 
Blue light was tested against a panel of 34 bacterial isolates (clinical and type strains) 37 
comprising: Acinetobacter baumannii, Enterobacter cloacae, Stenotrophomonas 38 
maltophilia, Pseudomonas  aeruginosa, Escherichia coli, Staphylococcus aureus, 39 
Enterococcus faecium, Klebsiella pneumoniae, and Elizabethkingia meningoseptica.  40 
 41 
 42 
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Results 43 
All planktonic phase bacteria were susceptible to blue light treatment, with the majority 44 
(71%) demonstrating a ≥5 log10 decrease in viability after 15-30 minutes exposure (54 45 
J/cm2 to 108 J/cm2). Bacterial biofilms were also highly susceptible to blue light, with 46 
significant reduction in seeding observed for all isolates at all levels of exposure. 47 
Conclusions 48 
These results warrant further investigation of blue light as a novel decontamination 49 
strategy for the nosocomial environment, as well as additional wider decontamination 50 
applications.   51 
 52 
Importance  53 
Blue light shows great promise as a novel decontamination strategy for the nosocomial 54 
environment, as well as additional wider decontamination applications (e.g. wound 55 
closure during surgery). This warrants further investigation.  56 
 57 
 58 
 59 
1 INTRODUCTION 60 
Antimicrobial resistance (AMR) is rapidly evolving and emerging to be a large threat to 61 
modern medicine. Although only affecting a minority of admissions, healthcare 62 
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associated infections are associated with increased mortality, prolonged hospital stays 63 
and increased treatment costs (1). With the rise in resistance to the carbapenem class 64 
of antibiotics in Gram-negative organisms (2), there is a significant threat of infections 65 
becoming wholly untreatable with current treatment regimens (3,4).  66 
Much research is now focussed on alternatives to the conventional antimicrobial agents. 67 
These mostly involve topical agents (with the aim to reduce surface contamination and 68 
therefore lower the risks of sepsis and infection progression) with research to date on a 69 
large number of agents. Since the environment is a key source of nosocomial 70 
pathogens (5), there has also been renewed focus on hospital cleaning and disinfection, 71 
especially via antimicrobial chemicals delivered in a novel way, including antimicrobial 72 
light sources (1,6). These novel strategies capable of decontaminating both the patient’s 73 
wound and the environment, offer to be highly beneficial in the fight against AMR and 74 
nosocomial infections.  75 
The blue wavelengths within the visible light spectrum (especially wavelengths between 76 
400 nm to 470 nm) are intrinsically antimicrobial and do not require additional 77 
exogenous photosensitizers to exert an antimicrobial effect (4). Photodynamic 78 
inactivation of both bacterial and fungal cells occurs as a result of photo-excitation of 79 
intracellular porphyrins (1) by blue light, leading to energy transfer and the production of 80 
highly cytotoxic reactive oxygen species (ROS); primarily singlet oxygen (1O2) (4, 7-9). 81 
All wavelengths from 400-425 nm can be used for microbial inactivation; however the 82 
optimal antimicrobial activity occurs at 405 nm, since this is the point in the 83 
electromagnetic spectra where maximum porphyrin excitation occurs (10). Although 84 
less germicidal compared to ultra-violet light (1), pathogens can be selectively 85 
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inactivated without damaging human cells and consequently blue light is considered 86 
much less detrimental to mammalian cells than ultra-violet (11,12).  One potential 87 
benefit of light-based antimicrobial therapies is an equal efficacy against drug sensitive 88 
and resitant members of target species (13,14).  89 
Blue light has been shown to exhibit a broad spectrum of antimicrobial effect against 90 
bacteria and fungi, although, generally the Gram-positive bacteria are considered to be 91 
more susceptible to blue light than the Gram-negatives (15,16).  Successful inactivation 92 
has been demonstrated in vitro against Staphylococcus aureus (including MRSA), 93 
Clostridium difficile (both spores and vegetative cells), Acinetobacter baumannii, 94 
Escherichia coli, S. epidermidis, Pseudomonas aeruginosa, Klebsiella pneumoniae, 95 
Streptococcus pyogenes, and Mycobacterium spp. (14-15, 17, 18). In addition to the 96 
key nosocomial pathogens, blue light is also effective against Propionibacterium acnes, 97 
and has been used topically to treat acne vulgaris (19, 20), and Helicobacter pylori, 98 
where blue light is used internally as a ‘light string’ to treat stomach infections (21). 99 
Owing to the mechanism of action of blue light, it is unlikely that viruses will be 100 
susceptible unless photosensitizers are added to enhance virucidal activity (22).   101 
The use of blue light for treatment of wound infections in vivo is an emerging 102 
technology.  To date blue light therapy has been shown to significantly reduce the 103 
bacterial burden of wounds infected with P.  aeruginosa (23), MRSA (24), and A. 104 
baumannii  (25), and saved the lives of mice subjected to potentially lethal burns 105 
contaminated with P. aeruginosa and A. baumannii (23, 25).  106 
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As well as clinical application for patient treatment, blue light is also a promising 107 
candidate for the control of problematic microorganisms in the clinical setting (e.g. the 108 
disinfection of air and exposed surfaces). In this regard, Bache et al (26) and Maclean 109 
et al (1) have performed studies with a new disinfection technology termed the HINS-110 
light environmental decontamination system (EDS) which delivers low-irradiance 405nm 111 
light continuously and is suitable for use in patient occupied settings. Evaluation studies 112 
performed by the latter authors showed that there was a statistically significant 90% 113 
reduction in numbers of culturable Staphylococci spp. following 24 hours of use in an 114 
unoccupied room (5), and reductions of 56-86% when used in burns isolation rooms 115 
occupied by MRSA-positive patients. Furthermore, when the system was no longer 116 
used, the room became recontaminated to levels similar to those pre-treatment.  117 
The vast majority of research on blue light has been carried out on bacteria in  their 118 
planktonic phase, dispersed evenly in a liquid medium. In nature this is rarely the case, 119 
since most bacteria aggregate to form complex communities within a matrix of 120 
extracellular polymeric substances termed a biofilm.  There are many advantages for 121 
this compared to planktonic growth which include: increased resistance to killing via 122 
antimicrobials, immune cells, chemicals and environmental stresses (27). Furthermore, 123 
once a biofilm has become established on a surface they are extremely hard to 124 
eradicate.  Medically, biofilms have been associated with a myriad of chronic infections, 125 
acute infections, colonisation of in-dwelling medical devices, and wound infections (27-126 
29). 127 
Since we know that the majority of clinical infections and environmental contamination 128 
involve microbial biofilms (30), this multi-centre in vitro study was performed to assess 129 
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the antibacterial activity of blue light against biofilms of a range of important nosocomial 130 
pathogens.   131 
 132 
2 MATERIALS AND METHODS 133 
A series of in vitro experiments were conducted with a panel of organisms (Table 1) to 134 
determine the efficacy of blue light (400 nm) against bacteria in a planktonic (free-135 
floating in broth) and biofilm (attached to a surface) mode of growth. The panel 136 
comprised well-characterised control and clinical isolates (in terms of their antibiogram 137 
and ability to form biofilms in vitro) and concentrated mostly on A. baumannii strains 138 
from a protracted outbreak at the Queen Elizabeth Hospital in Birmingham (QEHB) (31). 139 
A. baumannii is a key nosocomial pathogen which survives in hospital and healthcare 140 
environments despite conditions such as desiccation, nutrient starvation and 141 
antimicrobial chemicals (e.g. disinfectants) (332, 33). Despite stringent infection control 142 
practices, a large outbreak of A.baumannii occurred at QEHB where 65 patients tested 143 
positive during the outbreak period (July 2011 to February 2013).  The strains from this 144 
outbreak demonstrated a high degree of resilience to survival in the hospital 145 
environment and there was also evolution amongst the isolates over time to increase 146 
dessication resistance and biofilm formation capacity.  Additional A. baumannii isolates 147 
(representing genetically diverse strains) were tested in this panel to add some diversity 148 
to the strains, including strains ACI_AYE (a representative of International Clone I; a 149 
major globally relevant lineage), ACI_C60 (a control strain of a unique PFGE type), and 150 
ACI_19606 (a control strain of a further unique PFGE type) (typing data not shown).  151 
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 152 
We also tested a small range of other 'comparator' organisms commonly causing 153 
hospital acquired infection including Enterobacter cloacae, Stenotrophomonas 154 
maltophilia, P.  aeruginosa, E. coli, S. aureus, and Enterococcus faecium and included 155 
control strains (PS_6749 and MSSA_10788) recognised in the EN standards for 156 
assessing the efficacy of chemical disinfectants (e.g. EN 13727 (34)). The panel 157 
comprised isolates that in previous tests had demonstrated ability to form relevant 158 
quantitities of biofilm in vitro, and furthermore included two carbapenem (multi-drug) 159 
resistant isolates of K. pneumoniae, and a single isolate of Elizabethkingia 160 
meningoseptica from a wound swab. This is an intrinsically highly resistant organism, 161 
usually resistant to extended-spectrum ß-lactam agents (due to production by most 162 
strains of two betalactamases: one ESBL and one Class B carbapenem-hydrolyzing 163 
metallolactamase), aminogylcosides, tetracycline, and chloramphenicol (35).  164 
 165 
All isolates were stored at -80°C on Protect™ beads, and were routinely cultured on 166 
cysteine lactose electrolyte deficient (CLED) or blood agar prior to each experiment. 167 
 168 
Experiments were designed to assess the antibacterial activity of blue lightagainst 169 
planktonic and biofilm growth forms of the panel of bacteria described above. Testing 170 
was performed at the Defence Science Technology Laboratory (DSTL) (planktonic) and 171 
the Surgical Reconstruction and Microbiology Research Centre (biofilms), and blue light 172 
of 400 nm wavelength was used for all experiments.  173 
 174 
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2.1 Blue light equipment 175 
High intensity blue light was provided by a LED Flood array (Henkel-Loctite, Hemel 176 
Hempstead, UK).  This array utilises 144 reflectorized LEDs which produce a 177 
homogeneous illuminated area of 10 cm x 10 cm.  The emission spectrum of the LED 178 
array was determined using a USB2000 spectrophotometer (Ocean Optics, Oxford, 179 
UK). Two identical platforms were used for the testing, both of which were calibrated at 180 
DSTL using a PM100D radiant power meter (Thorlabs, Newton, New Jersey, USA) prior 181 
to in vitro testing to ensure a reproducible irradiance of 60 mW/cm2 when the LED array 182 
is positioned 15.5cm above the test area. All of the experimental conditions (except 183 
wavelength) adhere to the optimal criteria outlined by Coohill and Sagripanti (36) for the 184 
assessment of bacterial sensitivity to UV-C radiation. 185 
 186 
2.2 Impact of blue light on planktonic bacteria  187 
Bacterial isolates were grown overnight in Luria Broth (LB) [Sigma-Aldrich, UK], then 188 
diluted in sterile PBS to produce a starting concentration of approximately 1 x 106 189 
bacteria per ml.  Test samples (2ml) were inoculated into a 12-well microtitre plate 190 
[Corning, New York, USA], sealed with an optically clear ABsolute qPCR sealer 191 
[Thermo Fisher Scientific, Paisley, Scotland] to prevent evaporation, then exposed to  192 
blue light for 30 minutes (samples were taken for viable counting at 5 minute intervals). 193 
If the strains still showed viability after 30 minutes of blue light exposure, the test was 194 
repeated over 180 minutes, with samples taken at 20 minute intervals. An identical dark 195 
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control plate was set up, wrapped in aluminium foil and placed in the flood array 196 
adjacent  to the blue light irradiated samples.   197 
At time increments during the experiment blue light exposed and dark incubated 198 
samples were removed and viable bacteria enumerated by serial dilution and growth on 199 
LB agar plates.  The blue light sensitivity for each strain was determined from the mean 200 
of three independent biological replicates, with two technical replicates within each 201 
experiment. 202 
The blue light dose (J/cm2) received by the bacteria was calculated by multiplying the 203 
irradiance of light (W/cm2) to which the sample was exposed, by the exposure time 204 
(seconds).  205 
 206 
2.3 Impact of blue light on pre-formed biofilms 207 
The antibacterial activity of blue light against pre-formed biofilms was assessed by 208 
conducting ‘minimum biofilm eradication concentration’ (MBEC) experiments (37) on 209 
each isolate. Overnight LB cultures of the test strains (made by inoculating 210 
approximately three to five colonies into 5ml of fresh LB broth and incubating at 37°C 211 
overnight) were diluted in fresh antibiotic-free Mueller-Hinton (MH) broth to an OD600 of 212 
0.1 and then 200µl seeded into wells of a 96-well microtiter tray (MTT). Positive (200µl 213 
0.1 OD600 diluted organisms) and negative (200µl MH broth) controls were included per 214 
blue light time point to be tested.  215 
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To produce a ‘transferable biofilm’, a 96 well polypropylene plate [Starlabs, UK] was 216 
then placed into the MTT so that each well contained a ‘peg’, on which biofilms could 217 
form, before the plates were sealed, and statically incubated at 33°C for 72 hours. After 218 
72 hours, the pegs (±biofilm) were removed and washed in a MTT containing sterile 219 
water (to remove any unbound cells). The positive (bacteria only) and negative control  220 
(sterile broth only) ‘peg plate’ was placed in a clean, empty MTT and wrapped in foil. 221 
Following this, both the control and the test peg plate were placed in the test area 222 
(15.5.cm beneath the light source) and exposed to the blue light for time points of 15, 223 
30, 45 or 60 minutes (corresponding to a blue light dose of 54, 108, 162 and 216 J/cm2 224 
respectively). The foil around the control plate prevented the pegs from receiving any 225 
blue light treatment (and hence these positive control biofilms were not exposed to the 226 
blue light), but the control plate biofilms would have most likely been exposed to the 227 
same amount of heating and drying as the blue light exposed test plate.  228 
After the treatment, the peg plates were carefully placed into a MTT containing 200µl 229 
sterile MH broth (herein referred to as ‘reporter broth’) for overnight incubation. After 18 230 
hours, the OD of the reporter broth was measured to assess the viability (seeding) of 231 
the biofilms following blue light exposure.  232 
To demonstrate the presence of biofilms on the pegs, crystal violet (CV) assays were 233 
additionally performed on the pegs after the OD of the reporter broth had been 234 
measured. This involved placing the pegs into MTTs containing 200µl of 1% CV (which 235 
binds to any present microbial biomass of biofilm), followed by washing (to remove 236 
unbound CV) and subsequent solubilisation of the CV in 200µl of 70% ethanol. The peg 237 
biofilm biomass could then be measured using OD readings as previously and the 238 
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presence of the biofilm confirmed. Two biological and 10 technical replicates were 239 
performed for each strain and blue light exposure duration, respectively.  240 
 241 
2.4 Statistical analysis 242 
2.4.1 Planktonic tests 243 
For the planktonic data, the surviving fraction was determined from the quotient N/N0, 244 
with N = the number of colony formers of the irradiated sample and N0 that of the non-245 
irradiated controls. Plotting the logarithm of N/N0 as a function of dose (blue light fluence 246 
in J/cm²), allowed survival curves to be obtained.  247 
To determine the curve parameters, the following relationship was used: ln N/N0 = IC x 248 
F + n where:  N = the number of colony formers after blue light irradiation; N0 = the 249 
number of colony formers without irradiation; IC = inactivation constant (cm2/J); and n = 250 
extrapolation number, (i.e. the intercept with the ordinate of the extrapolated semi-log 251 
straight-line). The inactivation constant and the reciprocal lethal dose (LD) values were 252 
determined from the slope of the dose–effect-curves (linear portion of the curve).  253 
To allow for comparison with other bactericidal radiation sources in the literature, blue 254 
light mediated killing was calculated in terms of the inactivation constant slope (IC), and 255 
the kill kinetics shown as both the LD37  and LD90. The significance of the difference of 256 
the dose–effect-curves was statistically analyzed using student’s t-test. Differences with 257 
P values <0.05 were considered statistically significant. 258 
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LD90 values were analysed using the statistical software package IBM SPSS V21.0, 259 
were found to be log normal by QQ plot (data not shown), and were consequently 260 
transformed to the logarithm of 10 prior to parametric analysis. Differences between 261 
bacterial species was investigated using a 1 way ANOVA,  and the suitability of the data 262 
for parametric analysis was further established with the use of a Levene’s test for 263 
unequal variance (P=0.165). Where only one bacterial strain of species was available, 264 
this species was taken out of the analysis. Multiple comparisons were made using the 265 
Bonferroni’s correction. Similarly, the effect of pigmentation of S. aureus  strains on 266 
susceptibility to blue light was tested by using T-tests without Welches correction and 267 
suitability was further tested using Levene’s test for unequal variance (P=0.984). 268 
 269 
2.4.2 Biofilm tests 270 
The ability of biofilms to seed new growth following exposure to blue light was assessed 271 
by comparing the OD values at each blue light time point verses the untreated (positive) 272 
control, and significance was determined using the student’s t test. In order to 273 
investigate any possible link between biofilm size/depth (colourimetry), and blue light 274 
sensitivity, these two parameters were investigated through QQ plots in SPSS (version 275 
21.0; SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp). Initial 276 
analysis suggested a transformation of both parameters by the logarithm of 10 was 277 
needed to render the data suitable for parametric analysis (analysis not shown). Very 278 
little difference between the technical replicates was observed with regards to either 279 
parameter and therefore the median of the log10 of the technical replicates was used for 280 
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analysis. The capacity for each strain to form a biofilm was taken from the average of 281 
the OD values over the 4 time points for the positive control. Comparisons of biofilm 282 
values were made using 1 way ANOVA and students’ ‘t’ tests (without Welch’s 283 
correction) and comparisons of variances were made with F tests and Brown-Forsythe 284 
tests. The viability of each strain of bacteria in biofilm was analysed by Bonferroni’s 285 
posts tests across each time point (SPSS). Where significant differences between the 286 
positive control and the blue light occurred, the blue light was regarded as having an 287 
effect from there on leading to an ordinal score for each strain of 15 min (54 J/cm2), 30 288 
min (108 J/cm2), 45 min (162 J/cm2), 60 min (216 J/cm2),  or >60 min. Comparisons of 289 
biofilm sensitive scores were made using Kruskal-Wallis tests. 290 
In order to characterise whether correlation existed between measured parameters, the 291 
Spearman’s method was used. In order to determine the statistical power of the 292 
correlations, the computer program SPSS sample power V3.0 (IBM) was used and 293 
power was calculated for one sample correlations using the derived R value and the 294 
sample size (N = 34). 295 
 296 
3 RESULTS 297 
Blue light was tested against 34 bacterial isolates; including clinical isolates from QEHB 298 
and culture collection type strains. The results of the spectral output testing of the blue 299 
light platform (with an Ocean Optics USB2000 spectrometer), determined the emission 300 
peak of the blue light produced was at 400nm, with a full-width half maximum value of 301 
±8.5 nm (Fig. S1).  302 
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 303 
3.1  Sensitivity of isolates to blue light when grown in planktonic culture 304 
All 34 isolates were sensitive to blue light treatment, and there was no significant decay 305 
in the dark incubated controls. In contrast, rapid and substantive loss of viability was 306 
observed where all test bacteria were exposed to blue light (Figure 1A-F). 307 
Twenty four of the isolates (71%) demonstrated at least a 5 log10 decrease in viability 308 
following 15 (54 J/cm2) to 30 minutes (108 J/cm2) of blue light exposure (Table 2), and 309 
for the majority of these isolates (A. baumannii (12/12), S. aureus (4/5), S. maltophilia 310 
(2/3), E. meningoseptica (1/1)), there was a greater than 6 log10 decrease in viability. 311 
Ten of the 34 isolates showed <5 log10 decrease in viability. The isolates concerned 312 
included  E. cloacae (ENTCL_525, ENTCL_801, ENTCL_804), E. coli (EC_073, 313 
EC_042), K. pneumoniae (MDR_A, MDR_B), S. aureus (MSSA_10788), S. maltophilia 314 
(STEMA_551), and E. faecium (EFM_513). Four of the 34 isolates (E. cloacae 315 
(ENTCL_525, ENTCL_801, ENTCL_804) and E. faecium (EFM_513)), took longer to kill 316 
than the majority of isolates, requiring extended timepoints up to 120 minutes (432 317 
J/cm2) to obtain 2-3 log10 decrease in viability.  318 
Loss of bacterial viability associated with blue light was calculated as previously 319 
described to give LD90 values in terms of J/cm2. Investigation of these LD90 values 320 
indicated that differences between LD90 values were very likely driven by differences in 321 
the blue light susceptibility of different bacterial species (P<0.001). We found that the 322 
highest LD90 values belonged to E. cloacae and K. pneumoniae strains which had 323 
values statistically higher than all other species included in the analysis (where  more 324 
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than one representative strain was tested) (P<0.05 in all cases) (Figure 2). The 325 
exception to this was E. coli which had moderate blue light tolerance, but no statistical 326 
differences were seen between the strains tested . A. baumannii, S. aureus, P. 327 
aeruginosa and S. maltophilia all had similar and low levels of resistance to the blue 328 
light exposure. 329 
 330 
In the initial assay of planktonic cell resistance to blue light, we observed that the S. 331 
aureus strains demonstrated different colony pigmentation; appearing either as pale 332 
yellow (MRSA_508, MRSA_520, MRSA_531 and MSSA_F77) or orange 333 
(MSSA_10788) when grown on LB agar.  We hypothesised that this pigmentation may 334 
be responsible for the variability seen in both the survival fraction curves and LD90 335 
values when exposed to blue light (Figures 1B and 2). Four additional culture collection 336 
strains of S. aureus were assessed for blue light sensitivity, including two pale yellow 337 
(MSSA_29213, MSSA_10442) and two orange (MSSA_33807, MSSA_4163) strains. In 338 
total nine strains of S. aureus were tested, six yellow and three orange. We determined 339 
that the orange pigmentation correlated with increased resistance to blue light in both 340 
the survival fraction curves and in LD90 values (Figures 3A and B). The LD90 values 341 
were statistically significantly higher in the orange pigmented strains than in their yellow 342 
counterparts (P=0.003). 343 
 344 
3.2 Sensitivity of isolates to blue light when grown in biofilms 345 
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Blue light treatment resulted in reductions in biofilm seeding for all isolates tested 346 
(Figure 4A-C), and the majority of these reductions (apart from timepoint 15 minutes for 347 
MSSA_10788) were statistically significant (p-values <0.05 in student’s t-tests 348 
compared to the positive control). The percentage reductions are shown in table 3 with 349 
the single non-significant result denoted by a ^.   350 
The most susceptible isolates were the Gram negative organisms, and in particular 351 
ACI_19606, where there was a 93.5% reduction in biofilm seeding (p<0.001) after 15 352 
minutes (54 J/cm2) of blue light exposure. As a group, the other Gram negative 353 
comparator organisms were the most susceptible, with 10/16 (63%) showing greater 354 
than 80% reductions in biofilm seeding (average = 86%) at 15 minutes, compared to 355 
1/12 for A. baumannii and 1/6 for the Gram positive organisms.  Although ENTCL_804 356 
responded well to blue light treatment at 30 minutes/108 J/cm2 (46.6% reduction), 45 357 
minutes/162 J/cm2 (88.2% reduction), and 60 minutes/216 J/cm2 (87.8% reduction), the 358 
treatment actually resulted in increased biofilm seeding at 15 minutes of 18.7%. This 359 
result was repeatable and was seen in a number of replicates.  360 
As mentioned, the Gram positive biofilms were less susceptible to blue light treatment, 361 
with only two isolates (33%) achieving at least 90% reductions in seeding. It is important 362 
to note however the small sample size. One isolate of S. aureus (MSSA_10788), which 363 
is recognised in the EN standards for assessing the efficacy of chemical disinfectants 364 
was the least sensitive to blue light, achieving a maximum reduction in biofilm seeding 365 
of 36% at 45 minutes (162 J/cm2). This result was again repeatable and was seen in 366 
48replicate pegs. This is further evidence towards the hypothesis that bacterial 367 
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pigmentation attenuates the sensitivitiy to blue light, in biofilms as well as in planktonic 368 
cells. 369 
In order to characterise how the different biofilm forming properties (seeding ability and 370 
biofilm size) of each bacterial species relate to each other, a series of correlations were 371 
performed.  We found no evidence for significant correlations existing between i) 372 
median biofilm size (CV assay) and median sensitivity of biofilm to blue light (P = 373 
0.133), or ii) median biofilm size and LD90 (P = 0.912).  For these reasons we feel that 374 
any differences between species in biofilm resistance to blue light are likely to be 375 
intrinsic differences rather than a function of the biofilm. However, we are not able to 376 
dismiss the alternative hypothesis that correlations do exist as these analyses were 377 
insufficiently powered. We found the statistical power to be 21% when considering the 378 
potential correlation between planktonic and biofilm killing (R = 0.200) and 33% when 379 
considering the correlation between biofilm killing and biofilm formation (R = -0.263). In 380 
this respect, we must actually conclude that real correlations between these parameters 381 
might exist; however, if they do exist, they are likely to less apparent in comparison to 382 
the correlation observed between biofilm formation and planktonic killing. 383 
 384 
We found a significant correlation between the sensitivity of strains to blue light in the 385 
planktonic state and their ability to form biofilms (Spearman’s Coefficient = 0.369, P = 386 
0.032). This indicated that strains that demonstrated greater resistance to blue light in 387 
planktonic state were more likely to produce thicker biofilm. 388 
 389 
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 390 
4 DISCUSSION 391 
In this study, we have shown blue light (400 nm) to be effective at inactivating both 392 
planktonic cells and biofilms of important nosocomial wound pathogens. Contrary to 393 
published research (1,15,16), we found Gram negative organisms to be more 394 
susceptible to blue light. There are a number of differences between these published 395 
studies and our study which may contribute to these conflicting findings. Firstly, we 396 
tested a number of isolates per species (most of the studies test one strain of each 397 
species) comprising both clinical and control strains (most of the published studies use 398 
control strains which may have been passaged many times), and our light box exposed 399 
the bacteria to higher doses (60mW/cm2) than the 10mW/cm2 used by Maclean et al 400 
(15). Although we only tested a small number of isolates, the Gram positive biofilms 401 
appeared less sensitive to blue light treatment, with one strain (MSSA_10788) 402 
consistently resisting the effects of blue light.  403 
Analyzing blue light susceptibility against multiple clinical strains from the same species 404 
has permitted us to assess the heterogeneity of intra-species kill rates.  In some species 405 
such as A. baumannii the rate of blue light mediated killing was extremely 406 
homogeneous; however, S. aureus strains display a much more heterogeneous 407 
response to blue light stress.   408 
It has long been recognised that bacterial cells have utilised pigmentation as a virulence 409 
factor (38).  One of the most easily recognisable bacterial pigments are the triterpenoid 410 
carotenoids, which impart the eponymous golden colour to S. aureus strains.  Various 411 
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authors have identified a correlation between strains containing the carotenoid pigment 412 
staphyloxanthin and the ability to survive on surfaces exposed to natural sunlight (39), 413 
and it is well known that carotenoids function as antioxidants. 414 
Furthermore,  staphyloxanthin has been shown to provide protection for pigmented S. 415 
aureus strains against ROS produced by phagocytes (40, 41).  416 
Augmentation of the clinical isolates of S. aureus with a series of well characterized 417 
strains from culture collections allowed us to correlate increased blue light killing times 418 
(as seen with MSSA_10788) with colony pigmentation. Planktonic testing and 419 
assessment of the LD90 values per colour group, show that the light sensitivity of the 420 
strongly orange pigmented strains is significantly different to the standard pale yellow 421 
strains (p-value <0.003) (Figure 3B). Therefore, although all species of S. aureus tested 422 
were susceptible to blue light, it is important to consider the effects of bacterial 423 
pigmentation when determining the required blue light exposure for effective 424 
decontamination.  425 
As well as differences in sensitivity, there were also several instances where blue light 426 
treatment increased the planktonic growth and biofilm seeding. For example, with 427 
ENTCL_804, there was an increase of 18.7% in seeding after 15 minutes of blue light 428 
treatment. Light has been shown to facilitate growth when the wavelengths and dose 429 
are not appropriate (42), and Nussbaum et al (43) found that 810 nm and 905 nm 430 
improved the growth of E. coli and S. aureus, respectively. Furthermore, Mussi et al (44) 431 
reported that blue light treatment decreased motility and biofilm formation in A. 432 
baumannii, and increased pathogensis when co-cultured with Candida albicans (a 433 
model for apoptosis in human alveolar macrophages) (45). However, there are several 434 
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important differences between studies; the fluence was considerably lower than in this 435 
study (1.32-1.89 mW/cm2 verses 60 mW/cm2) and the light wavelength peaked at 460 436 
nm verses 400 nm, while the exposure was measured over 4 days verses 30 minutes. 437 
However, it does raise interesting questions on the effects of suboptimal light exposure 438 
on bacterial cells which should be looked into in future studies. Furthermore, the 439 
enhanced growth in our study warrants further investigation.   440 
We found that, a correlation existed between the strains which were sensitive to blue 441 
light in planktonic state and those which produced larger amounts of biofilm in the CV 442 
assay. The reason for this observation is not clear in this investigation; however we 443 
hypothesise that this indicates that blue light selective pressure may exist in 444 
environmental niches where protection as a biofilm might provide benefits against other 445 
stimuli that are likely to co-exist with blue light. The fact that we were unable to observe 446 
a correlation between biofilm and planktonic resistance to blue light might indicate that 447 
these mechanisms are functionally independent. Planktonic cells need to rely on their 448 
intrinsic transparency, pigmentation and repair to protect against blue light. In biofilm 449 
bacteria can rely on more extracellular exudate and neighbours to protect against blue 450 
light. 451 
To the best of our knowledge, our work is one of the first to show the antibacterial 452 
activity of 400 nm light against a range of clinically relevant bacterial strains (as well as 453 
control strains), and one of just a handful to look at non-dental biofilms.  The inclusion of 454 
multiple isolates is an additional strength of the paper as it allows correlations between 455 
phenotypic characteristics and blue light resistance to be explored.  Although there are 456 
several limitations (monomicrobial biofilms tested instead of polymicrobial, no formal 457 
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assessment of the potential for the development for resistance, the relatively small 458 
number of isolates tested, and the potential biasing effect of the included resistant 459 
isolates), our work nonetheless provides valuable insights into this technology, and 460 
especially how it relates to the eradication of biofilms for environmental 461 
decontamination.  462 
The findings in this paper demonstrate that high intensity blue light can be used to 463 
inactivate a wide range of clinical pathogens, not only in the planktonic state but also as 464 
mature biofilms.  This technology has many practical applications within healthcare 465 
settings, as blue light may ameliorate opportunistic infections indirectly by reducing the 466 
bacterial load on environmental surfaces and directly within wounds.  Future studies are 467 
warranted to investigate this further, and especially whether the exposure times of the 468 
400 nm blue light can be reduced for a range of different clinical applications. As blue 469 
light is equally efficacious against antibiotic resistant pathogens, this technology may 470 
prove an important weapon in the future fight against antimicrobial resistance. 471 
 472 
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 620 
 621 
 622 
Figure Legends: 623 
Figure 1. Survival of planktonic bacteria after exposure to 400 nm blue light. 624 
Strains:  A. Acinetobacter baumannii strains: closed circles (• ACI_616; open circles ACI_618; closed 625 
triangles up ACI_AYE; open triangles up ACI_665; closed triangles down ACI_19606; open triangles down 626 
ACI_648; closed diamonds ACI_659; open diamonds ACI_C60; closed squares ACI_671; open squares 627 
ACI_672; closed hexagons ACI_698; open hexagons ACI_642. 628 
B.  Staphylococcus aureus:  open circles MSSA _10788; closed triangles up: MSSA_F77; closed squares 629 
MRSA_520; open triangles up MRSA_531; closed circles MRSA_508 630 
C.  Stenotrophomonas maltophilia: circles STEMA_ 558; triangles up STEMA_551; squares STEMA_529 631 
D.  Enterobacter cloacae: circles ENTCL_804; triangles up ENTCL_801; squares ENTCL_525 632 
E.  Pseudomonas aeruginosa:  closed circles: PSE_1586; open circles PSE_PAO1; closed triangles up 633 
PSE_568; closed squares PSE_1054; open squares PSE_6479 634 
F.  Other: E. coli EC_042 open circles: E. coli EC_073 closed circles; K. pneumoniae MDR-A open squares: 635 
K. pneumoniae MDR-B closed squares; Elizabethkingia meningoseptica open triangles up EKIN_502; 636 
Enterococcus faecium EFM_513 open triangles down 637 
Data are averages ± standard deviations (n = 3). 638 
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Figure 2.  Comparison of blue light LD90 values between strains and species.  Each 639 
individual circle represents the average LD90 for each strain ± standard deviations (n = 640 
3).  The average LD90 value for each species is shown by horizontal lines. 641 
 642 
Figure 3. A.  Correlation between survival of planktonic S. aureus strains following blue 643 
light exposure, and cell pigmentation.   644 
Orange carotenoid producing strains: closed circles MSSA_4163; closed triangles down MSSA-33807; 645 
closed triangles up MSSA_10788.  Yellow non-carotenoid producing strains: open circles MSSA_10442; 646 
open squares MSSA_F77; open diamonds MRSA_520; open triangles down MRSA_531; open triangles 647 
up MRSA_508; open hexagons MSSA_29213.  Data are averages ± standard deviations (n = 3). 648 
 649 
B.  Comparison of blue light LD90 values between yellow and orange pigmented S. 650 
aureus strains.   651 
Each individual circle represents the average LD90 for each strain ± standard deviations (n = 3).  The 652 
average LD90 value for yellow and orange pigmented strains is shown by horizontal lines. 653 
 654 
Figure 4, A-C: Graphs showing the biofilm seeding results for all isolates.  655 
Optical density on the y axis refers to the average biofilm seeding for the isolates tested after 656 
exposure to blue light (BL) at the range of durations tested (in minutes) on the x axis. Positive 657 
control: refers to the average biofilm seeding of the dark incubated, non blue light exposed 658 
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isolates. Negative control: refers to a negative (broth only) control. The error bars represent the 659 
standard error.  660 
 661 
 662 
 663 
Tables:  664 
Table 1: List of the clinical and control isolates used in this study. 665 
Table 2: Antimicrobial effects of blue light on planktonic cells  666 
Table 3: Average percentage change in biofilm seeding in isolates exposed to blue light 667 
compared to non-exposed dark incubated controls  668 
 669 
 670 
Supplementary: 671 
Figure S1: Emission spectrum of Henkel Loctite blue light array determined using an 672 
Ocean Optics USB2000 spectrometer 673 
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Table 1: List of the clinical and control isolates used in this study. 
Study Identifier Organism Description 
ACI_616 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_618 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_642 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_648 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_659 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_665 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_671 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_672 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_698 Acinetobacter baumannii QEHB clinical outbreak isolate  
ACI_AYE Acinetobacter baumannii MPR Clinical Isolate (unique) 
ACI_C60 Acinetobacter baumannii NCTC_13424 (unique) 
ACI_19606 Acinetobacter baumannii ATCC_19606 (unique) 
ENTCL_525 Enterobacter cloacae complex QEHB clinical isolate 
ENTCL_801 Enterobacter cloacae complex QEHB clinical isolate 
ENTCL_804 Enterobacter cloacae complex QEHB clinical isolate 
STEMA_529 Stenotrophomonas maltophilia QEHB clinical isolate  
STEMA_551 Stenotrophomonas maltophilia QEHB clinical isolate  
STEMA_558 Stenotrophomonas maltophilia  QEHB clinical isolate  
PSE_568 Pseudomonas aeruginosa QEHB clinical isolate 
PSE_PA01 Pseudomonas aeruginosa ATCC_15692  
PSE_6749 Pseudomonas aeruginosa NCTC_6749  
PSE_1054 Pseudomonas aeruginosa QEHB Clinical burn isolate  
PSE_1586 Pseudomonas aeruginosa QEHB Clinical burn isolate  
EKIN_502 Elizabethkingia meningoseptica QEHB clinical isolate 
EC_073 Escherichia coli EPEC CFT_073 
EC_042 Escherichia coli EAEC_042 
MDR_A CPE^ Klebsiella pneumoniae  
(NDM-1
+
 positive) 
QEHB Clinical isolate 
MDR_B 
 
CRE* Klebsiella pneumoniae  
(ESBL positive with additional 
permeability changes) 
QEHB Clinical isolate 
MRSA_508 Staphylococcus aureus QEHB Clinical isolate 
MRSA_520 Staphylococcus aureus QEHB Clinical isolate 
MRSA_531 Staphylococcus aureus QEHB Clinical isolate 
MSSA_10788 Staphylococcus aureus NCTC_10788 
MSSA_F77 Staphylococcus aureus NCTC_8532 
EFM_513 Enterococcus faecium QEHB Clinical isolate 
MSSA_29213 Staphylococcus aureus ATCC_29213 
MSSA_10442 Staphylococcus aureus NCTC_10442 
MSSA_33807 Staphylococcus aureus ATCC_33807 
MSSA_4163 Staphylococcus aureus NCTC_4163 
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Table 2: Antimicrobial effects of blue light on planktonic cells 
   
          
Isolate  
Exposure 
time 
Irradiance Dose 
Log10 
reduction 
P-value 
LD37 value  LD90 value  
(minutes) mW/cm
2
 J/cm
2
 J/cm2 J/cm2 
ACI_616 30 60 108 7.06 0.006 21 ± 2 27 ± 2 
ACI_618 30 60 108 5.78 0.007 55 ± 4 59 ± 3 
ACI_642 30 60 108 6.73 0.006 9 ± 1 16 ± 2 
ACI_648 30 60 108 6.14 0.007 21 ± 2 29 ± 3 
ACI_659 30 60 108 6.55 0.006 8 ± 1 16 ± 2 
ACI_665 30 60 108 6.14 0.006 7 ± 1 12 ± 1 
ACI_671 30 60 108 6.34 0.006 25 ± 2 32 ± 4 
ACI_672 30 60 108 6.22 0.006 16 ± 2 24 ± 2 
ACI_698 30 60 108 6.39 0.008 9 ± 1 14 ± 2 
ACI_AYE 30 60 108 6.70 0.006 10 ± 1 16 ± 2 
ACI_C60 30 60 108 6.76 0.007 7 ± 1 14 ± 1 
ACI_19606 30 60 108 6.81 0.006 7 ± 1 13 ± 1 
ENTCL_525 100 60 360 6.76 0.006 113 ± 12 136 ± 19 
ENTCL_801 180 60 648 6.61 0.009 212 ± 20 246 ± 25 
ENTCL_804 160 60 576 6.24 0.007 258 ± 18 306 ± 24 
STEMA_529 30 60 108 7.21 0.006 7 ± 1 12 ± 2 
STEMA_551 30 60 108 2.97 0.006 26 ± 3 48 ± 5 
STEMA_558 30 60 108 7.33 0.006 8 ± 1 18 ± 2 
PSE_568 30 60 108 6.48 0.002 6 ± 1 12 ± 2 
PSE_PA01 30 60 108 5.59 0.001 6 ± 1 17 ± 3 
PSE_6749 30 60 108 6.55 0.009 7 ± 1 13 ± 
PSE_1054 30 60 108 6.01 0.002 9 ± 1 15 ± 2 
PSE_1586 30 60 108 6.07 0.002 13 ± 2 22 ± 2 
EKIN_502 15 60 54 6.79 0.006 1 ± 0.5 4 ± 3 
EC_073 30 60 108 4.71 0.006 56 ± 4 64 ± 7 
EC_042 30 60 108 1.55 0.006 74 ± 8 85 ± 9 
MDR_A 140 60 504 6.88 0.002 124 ± 18 159 ± 25 
MDR_B 140 60 504 6.61 0.007 185 ± 16 219 ± 22 
MRSA_508* 30 60 108 6.17 0.002 12 ± 1 21 ± 3 
MRSA_520* 15 60 54 6.82 0.002 1 ± 0.5 5 ± 1 
MRSA_531* 30 60 108 6.41 0.001 7 ± 1 15 ± 2 
MSSA_10788 ^ 80 60 288 7.07 0.001 99 ± 12 118 ± 15 
MSSA_ F77* 30 60 108 6.76 0.006 3 ± 1 12 ± 2 
EFM_513 180 60 648 1.86 0.007 277 ± 16 393 ± 20 
Additional S. aureus isolates (for pigmentation investigation)       
ATCC_29213* 30 60 108 6.76 0.002 5 ± 1  15 ± 2 
NCTC_10442* 30 60 108 6.69 0.002 8 ± 1 20 ± 2 
ATCC_33807 ^ 80 60 288 7.01 0.002 15 ± 2 40 ± 5 
NCTC_4163 ^ 80 60 288 6.07 0.003 38 ± 5 71 ± 6 
Where * yellow pigmentation, ^ orange pigmentation,  LD37 and LD90 values are expressed  standard deviation 
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 Table 3: Average percentage change in biofilm seeding in isolates exposed to blue light compared to 
non-exposed dark incubated controls  
 
Study 
Identifier 
Average change in biofilm seeding (%) with blue light exposure 
 
15 minutes 
(54 J/cm2) 
30 minutes 
(108 J/cm2) 
45 minutes 
(162 J/cm2) 
60 minutes 
(216 J/cm2) 
 
ACI_616 -75.9 -92.4 -96.5 -94.5 
ACI_618 -39 -71.1 -85.6 -91.3 
ACI_642 -45.6 -69.8 -77.3 -76.3 
ACI_648 -43.7 -83 -78.2 -81.4 
ACI_659 -47.1 -88.6 -94.1 -94.3 
ACI_665 -53.9 -69.9 -82.5 -92 
ACI_671 -37.4 -60.6 -65.7 -79.9 
ACI_672 -31.1 -77.7 -76.5 -90.7 
ACI_698 -36.7 -87.3 -92.2 -93.7 
ACI_AYE -41.9 -76.2 -86.7 -95.5 
ACI_C60 -60.4 -89 -93.3 -94.8 
ACI_19606 -93.5 -94.6 -93.2 -94.3 
ENTCL_525 -34.9 -86.1 -92.2 -92.6 
ENTCL_801 -61.3 -94.6 -95.6 -96.4 
ENTCL_804 +18.7 -46.6 -88.2 -87.8 
STEMA_529 -80.7 -81 -92.4 -95.1 
STEMA_551 -84.5 -95.1 -96.2 -94 
STEMA_558 -71 -93.3 -96.2 -94.7 
PSE_568 -83.9 -82.8 -87.2 -81.8 
PSE_PA01 -83.7 -86.2 -82.8 -89.5 
PSE_6749 -88.9 -90.3 -87.1 -88.9 
PS_1054 -58.3 -90.7 -83.2 -84.3 
PSE_1586 -80.3 -92.0 -89.4 -88.8 
EKIN_502 -85.8 -94.8 -91.6 -86.5 
EC_073 -93.0 -94.6 -96.2 -96.2 
EC_042 -92.1 -91.3 -92.1 -93.4 
MDR_A -87.4 -96.0 -89.2 -82.4 
MDR_B -75.3 -95.0 -95.8 -94.3 
MRSA_508 -59.5 -58 -73.7 -83.3 
MRSA_520 -44.5 -57.7 -73.2 -78.8 
MRSA_531 -81.6 -91.2 -88 -93.7 
MSSA_10788 -5.0 ^  -30.9 -36.3 -34.6 
MSSA_F77 -67.8 -79.6 -96.4 -92.0 
EFM_513 -66.3 -69.3 -68.2 -72.2 
^ p value = 0.15. Shading denotes reductions of at least 80% in biofilm seeding compared to the 
positive control  
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